Interestingly, our studies also suggest that PTEN can modulate the sensitivity of Ewing Sarcoma cells to the microtubule inhibitor vincristine, a relevant conventional chemotherapeutic agent in this cancer. This evidence concerns the gene PTEN and Ewing sarcoma.